Volume 143, Issue 5, Pages e166S-e190S (May 2013)

Slides:



Advertisements
Similar presentations
Preoperative Pulmonary Function Evaluation in Lung Resection Ri 李佩蓉 / 王奐之 CR 顏郁軒.
Advertisements

Prediction of post operative Lung Volumes and Function
P RE OPERATIVE EVALUATION FOR PULMONARY SURGERY Chananya Karunasumetta, MD. Division of Cardiothoracic Surgery Department of Surgery Queen Sirikit Heart.
Pre-Operation Evaluation of Thoracic Surgery Patient: Spirometry and Pulmonary Exercise test (PXT) 吳惠東.
Pulmonary Physiologic Assessment of Operative Risk.
Management of Respiratory Diseases Part 1 Jed Wolpaw MD, M.Ed.
Treatment of Stage I and II Non-small Cell Lung Cancer
Colloquium on Therapy of Right Heart Failure
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
Volume 143, Issue 5, Pages e93S-e120S (May 2013)
Volume 56, Issue 1, Pages (July 1969)
Causes of Death in Carcinoma of the Lung in a Large Public Hospital
Volume 138, Issue 3, Pages (September 2010)
The Utility of Exercise Testing in Patients with Lung Cancer
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Exercise Conditioning and Cardiopulmonary Fitness in Cystic Fibrosis
Air Pollution and Chest Disease
Figure 1. Suggested algorithm for locoregional lymph node staging in patients with non-metastatic NSCLC. CT, computed tomography; EBUS, endoscopic bronchial.
Special Treatment Issues in Non-small Cell Lung Cancer
Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome  Henry J. Silverman, M.D., F.C.C.P. 
An Evaluation of 95 Consecutive Pulmonary Resections for Tuberculosis*
Prediction of post operative Lung Volumes and Function
Screening for Lung Cancer
Volume 141, Issue 2, Pages (February 2012)
Role of the CHADS2 Score in Acute Coronary Syndromes
The Lung Cancer Stage Page
Glenn N. Levine et al. JACC 2016;68:
Treatment of Small Cell Lung Cancer
Manuel Caceres, MD, Darryl S. Weiman, MD, JD 
Diagnostic Surgical Pathology in Lung Cancer
Volume 143, Issue 5, Pages e437S-e454S (May 2013)
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery  Stephen.
Volume 143, Issue 5, Pages e93S-e120S (May 2013)
Treatment of Stage I and II Non-small Cell Lung Cancer
Acute Pulmonary Exacerbations of Sarcoidosis
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238  Gregory M. Loewen, DO, Dorothy.
Volume 143, Issue 5, Pages e166S-e190S (May 2013)
Treatment of Tobacco Use in Lung Cancer
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
The Utility of Exercise Testing in Patients with Lung Cancer
Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD 
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome  Jean Perentes, MD, PhD, Sabina Bopp,
Decortication after 35 Years
Defining operative mortality: Impact on outcome reporting
Volume 146, Issue 6, Pages (December 2014)
A New Method to Predict Postoperative Lung Function: Quantitative Breath Sound Measurements  Frank Detterbeck, MD, Merav Gat, MS, Daniel Miller, MD, Seth.
Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS 
Vibration Response Imaging in Prediction of Pulmonary Function After Pulmonary Resection  Hyun Koo Kim, MD, PhD, DaeGwang Yoo, MD, Ho Kyung Sung, MD,
Volume 143, Issue 5, Pages e121S-e141S (May 2013)
Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients  Jie Dai, PhD,
Treatment of Stage I and II Non-small Cell Lung Cancer
Risk Stratification and Interventional Cardiology: Robert L
Rebuttal From Dr Mazzone
Volume 143, Issue 5, Pages e263S-e277S (May 2013)
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Mark F. Berry, MD, Chi-Fu Jeffrey.
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C
Cumulative count of the different primary pulmonary function test (PFT) outcomes in longitudinal studies of systemic sclerosis-associated interstitial.
Volume 115, Issue 6, Pages (June 1999)
Thoracic Surgery Survey on Lung Cancer Management
Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods  Alessandro Brunelli,
Volume 133, Issue 4, Pages (April 2008)
Occult renal dysfunction: a mortality and morbidity risk factor in coronary artery bypass grafting surgery  Antonio Miceli, MD, Vito D. Bruno, MD, Radek.
Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization  Philippe Kolh, MD, PhD, Paul Kurlansky,
Progression in the patient’s pulmonary function tests from 2010 to a) Forced vital capacity (FVC); b) total lung capacity (TLC); c) diffusing capacity.
Treatment of Stage III Non-small Cell Lung Cancer
Presentation transcript:

Volume 143, Issue 5, Pages e166S-e190S (May 2013) Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery  Alessandro Brunelli, MD, FCCP, Anthony W. Kim, MD, FCCP, Kenneth I. Berger, MD, FCCP, Doreen J. Addrizzo-Harris, MD, FCCP  CHEST  Volume 143, Issue 5, Pages e166S-e190S (May 2013) DOI: 10.1378/chest.12-2395 Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 1 [Sections 2.4, 3.0, 4.0] Physiologic evaluation cardiac algorithm. *ThRCRI.48 Pneumonectomy: 1.5 points; previous ischemic heart disease: 1.5 points; previous stroke or transient ischemic attack: 1.5 points; creatinine > 2 mg/dL: 1 point. ACC = American College of Cardiology; AHA = American Heart Association; CABG = coronary artery bypass graft surgery; CPET = cardiopulmonary exercise test; PCI = percutaneous coronary intervention. Modified and reproduced with permission of the European Respiratory Society. Eur Respir J. July 2009 34:17-41. doi:10.1183/09031936.00184308 CHEST 2013 143, e166S-e190SDOI: (10.1378/chest.12-2395) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 2 [Section 4.0] Physiologic evaluation resection algorithm. (a) For pneumonectomy candidates, we suggest to use Q scan to calculate predicted postoperative values of FEV1 or DLCO (PPO values =preoperative values × (1 – fraction of total perfusion for the resected lung), where the preoperative values are taken as the best measured postbronchodilator values. For lobectomy patients, segmental counting is indicated to calculate predicted postoperative values of FEV1 or DLCO (PPO values =preoperative values × (1 – y/z), where the preoperative values are taken as the best measured postbronchodilator value and the number of functional or unobstructed lung segments to be removed is y and the total number of functional segments is z. (b) PpoFEV1 or ppoDLCO cut off values of 60% predicted values has been chosen based on indirect evidences and expert consensus opinion. (c) For patients with a positive high-risk cardiac evaluation deemed to be stable to proceed to surgery we suggest to perform both pulmonary function tests and cardiopulmonary exercise test for a more precise definition of risk. (d) Definition of risk: Low risk: The expected risk of mortality is below 1%. Major anatomic resections can be safely performed in this group. Moderate risk: Morbidity and mortality rates may vary according to the values of split lung functions, exercise tolerance and extent of resection. Risks and benefits of the operation should be thoroughly discussed with the patient. High risk: The risk of mortality after standard major anatomic resections may be higher than 10%. Considerable risk of severe cardiopulmonary morbidity and residual functional loss is expected. Patients should be counseled about alternative surgical (minor resections or minimally invasive surgery) or nonsurgical options. ppoDLCO = predicted postoperative diffusing capacity for carbon monoxide; ppoDLCO% = percent predicted postoperative diffusing capacity for carbon monoxide; ppoFEV1 = predicted postoperative FEV1; ppoFEV1% = percent predicted postoperative FEV1; SCT = stair climb test; SWT = shuttle walk test; VO2max = maximal oxygen consumption. See Figure 1 legend for expansion of other abbreviations. CHEST 2013 143, e166S-e190SDOI: (10.1378/chest.12-2395) Copyright © 2013 The American College of Chest Physicians Terms and Conditions